Crescita Therapeutics Inc (CTX) — Capital Reinvestment Ratio
Crescita Therapeutics Inc (CTX) has a Capital Reinvestment Ratio of 1.74x as of December 2025, meaning it reinvests 2% of its operating cash flow (CA$416.00K) in capital expenditures (CA$724.00K). See CTX net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Crescita Therapeutics Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Crescita Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods. Check Crescita Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Crescita Therapeutics Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Crescita Therapeutics Inc from 2019 to 2025. For live market cap and broader valuation context, see Crescita Therapeutics Inc (CTX) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CA$1.07 Million | CA$333.00K | ▼ -28.6% |
| 2024 | 0.43x | CA$2.73 Million | CA$1.19 Million | ▲ +578.8% |
| 2023 | 0.06x | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.01x | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.04x | CA$5.31 Million | CA$215.00K | — |